In addition, our results is strengthened by a recent report that TLR4−/− or TLR4 antagonist-treated mice are highly refractory to influenza-induced lethality, due to blocking inflammation by host-derived, oxidized phospholipid that potently stimulates TLR4 [50], [51]. Here, TLR4 is linked to influenza.